These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 322770)

  • 1. Depressed in vitro lymphocyte responses to PHA in patients with Hodgkin disease in continuous long remissions.
    Case DC; Hansen JA; Corrales E; Young CW; Dupont B; Pinsky CM; Good RA
    Blood; 1977 May; 49(5):771-8. PubMed ID: 322770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease.
    Case DC; Hansen JA; Corrales E; Young CW; Dupont B; Pinsky CM; Good RA
    Cancer; 1976 Oct; 38(4):1807-15. PubMed ID: 1086708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.
    Fuks Z; Strober S; Bobrove AM; Sasazuki T; McMichael A; Kaplan HS
    J Clin Invest; 1976 Oct; 58(4):803-14. PubMed ID: 135001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological study of patients with Hodgkin's disease in long-lasting not-maintained complete remission.
    Gobbi M; Fiacchini M; Tomasini I; Ruggero D; Lauria F; Tura S
    Boll Ist Sieroter Milan; 1977 Mar; 56(2):144-51. PubMed ID: 326273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [T- and B-lymphocyte changes in lymphogranulomatosis].
    Il'in NV; Vinokurova NA; Gershanovich ML; Letskiĭ VB
    Vopr Onkol; 1979; 25(6):19-22. PubMed ID: 380155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative study of T and B lymphocytes in Hodgkin's disease.
    Bensa JC; Micouin C; Schaerer R; Sotto JJ; Hollard D
    Biomedicine; 1977 Apr; 26(2):137-44. PubMed ID: 326312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.
    Bobrove AM; Fuks Z; Strober S; Kaplan HS
    Cancer; 1975 Jul; 36(1):169-79. PubMed ID: 54208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [T and B lymphocytes in chronic lymphocytic leukemia and Hodgkin's disease. Electron microscopic and immunologic studies].
    Cohnen G
    Veroff Pathol; 1975; (0):1-99. PubMed ID: 49138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro lymphocyte dysfunction in Hodgkin's disease.
    Graze PR; Perlin E; Royston I
    J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of splenectomy on cellular immunologic parameters in Hodgkin's disease.
    Wagener DJ; Geestman E; Borgonjen A; Haanen C
    Cancer; 1976 May; 37(5):2212-9. PubMed ID: 130968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressor cell activity in a male infant with T-and B-lymphocyte dysfunction treated with thymosin.
    Hanson LA; Lindholm L; Carlsson B; Fasth A; Fälström SP; Wadsworth C; Värendh G
    Scand J Immunol; 1976; 5(10):1227-31. PubMed ID: 1087748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological markers and breast cancer. A multiparametric study. II. Depressed immune competence.
    Mandeville R; Lamoureux G; Legault-Poisson S; Poisson R
    Cancer; 1982 Oct; 50(7):1280-8. PubMed ID: 6980699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate analysis of T-cell functional defects and circulating serum factors in Hodgkin's disease.
    Schulof RS; Bockman RS; Garofalo JA; Cirrincione C; Cunningham-Rundles S; Fernandes G; Day NK; Pinsky CM; Incefy GS; Thaler HT; Good RA; Gupta S
    Cancer; 1981 Aug; 48(4):964-73. PubMed ID: 6456060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible nonspecific immunopotentiation by 2,4-dinitrochlorobenzene sensitization in patients with Hodgkin's disease.
    Rubinstein A; Ghossein NA; Melamed J; Bosworth JL; Murphy RA
    Oncology; 1979; 36(1):23-6. PubMed ID: 313034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
    Pluzańska A
    Haematol Blood Transfus; 1977; 20():203-7. PubMed ID: 305396
    [No Abstract]   [Full Text] [Related]  

  • 20. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.